Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. - Wikidata - wikimedia - TriplyDB

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.

http://www.wikidata.org/entity/Q33356349

about

Image guided surgery for the resection of brain tumours In vivo bio-imaging using chlorotoxin-based conjugates The Art of Intraoperative Glioma Identification.Treating malignant glioma in Chinese patients: update on temozolomide Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis Adjuncts for maximizing resection: 5-aminolevuinic acid Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.Porphyrins as theranostic agents from prehistoric to modern times.Topical application of activity-based probes for visualization of brain tumor tissue The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review.Through the patient's eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma.Treatment of glioblastoma in elderly patients.The value of extent of resection of glioblastomas: clinical evidence and current approach.Intraoperative assistive technologies and extent of resection in glioma surgery: a systematic review of prospective controlled studies.Survival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomas Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studies Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort.Current data and strategy in glioblastoma multiforme Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection Fluorescence-guided surgery and biopsy in gliomas with an exoscope system.Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker.Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model.Glioblastoma: changing expectations?A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma.Tumour-infiltrating T-cell subpopulations in glioblastomas.δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy Review of Neurosurgical Fluorescence Imaging Methodologies.Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.Long-Term Survival of a Patient with Giant Cell Glioblastoma: Case Report and Review of the Literature Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.Experimental approaches for the treatment of malignant gliomas.Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid).RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.The prognosis of anaplastic astrocytoma with radiologic necrosis mimicking glioblastoma.5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening

P2860

Q24200959-704AEB45-02FD-4730-87D0-BAF99434669D Q24595399-28BD1FC5-5943-4B41-954A-787B164EC0F3 Q26797281-E3EAC8BC-5EA6-4322-BEAC-9A7F89BCD816 Q26863755-C178D447-B8A0-48E9-A11A-908463D7E0EE Q26865296-5037AB7F-71BF-4A6A-AAB0-508572DA66F0 Q26999253-3F688711-EB38-442A-B003-266DCB4F4FF0 Q27310843-7BD4FE51-888F-4197-A5A8-B8538C475D72 Q28716876-94A9CFEB-F3BC-4211-AF77-EDEA20749C05 Q28731330-41B6416D-020C-4015-859C-13100665E2B8 Q30250298-7F2EB130-062D-4FB6-B643-BC38E0F50282 Q30363967-1B14E71D-6721-4A6C-99D3-49791BCD4C3F Q30838145-5A8A06BF-A9B9-44C7-B753-C33A7F607AA1 Q30873962-AA408169-6F68-4FE2-8D43-E9AA001076BF Q30873985-B0963E2D-B664-4546-B101-9E7C705865A5 Q31033595-12405D00-B0DF-4A68-889B-42390D1A2900 Q31118506-80B65D0A-D665-407A-A177-4F37CF58FD65 Q33416917-2D609CD3-2215-4A42-80B5-DEB44F97AB51 Q33527073-02EDE5E1-664F-42B0-BEF3-1BA0AADE0F20 Q33620235-38F32C60-66E2-43B3-8C88-1710D98CCC23 Q33747371-1B01D6AC-846D-48D2-BF3F-067167194295 Q33760618-1788BF44-124C-4BB0-AF8A-5FB15F37AA85 Q33832441-BD6A5C68-4078-45DE-9C01-256BEFE8E3A2 Q33856249-96B1AA59-DBD2-4E95-ACFE-E054482F128A Q33872581-9B3FA9A9-0E37-45A2-8004-920BAB2D3288 Q33873093-9AE42C79-AA4B-4CA1-8629-CDB557B0C8A6 Q33913465-B3BC597C-F816-434A-9E64-8FD6F0BEE768 Q33943553-F643B323-E0A2-48D5-A437-7C34EA82732F Q33974708-23E51ECD-4B14-44CA-95ED-25189F785805 Q34023717-9749E80A-BF35-4236-975F-61E4247A053E Q34048935-3C42FC71-68A1-45EA-ACEF-2F2B8A3FB57F Q34054790-8B530B94-1BA4-40A3-9A1A-9D23A36B9E22 Q34063357-3C774AEF-55F5-4951-9DC7-0D000DEE8728 Q34127138-C6AE27FC-1EF3-4751-92BF-32C9319D332E Q34132971-8DC4C8BC-C821-4E94-BFB5-579CE1B727E5 Q34322841-21C0A65A-EAE2-4884-AB8A-AB7B9A3CF4CC Q34349820-595586B7-AB3C-40E4-9918-558FCE8B70EB Q34349906-91D81F53-6EF8-47FE-A87D-98903DB71BBB Q34387771-9A5CEE22-FE97-47B2-848D-E8546F9C912B Q34471323-90E7019E-33A7-4311-9188-29429B3409A2 Q34700347-8927AAF8-1052-4E1C-B663-0EBE0C591736

P2860

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.

http://www.wikidata.org/entity/Q33356349

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Resection and survival in glio ...... nalysis of ALA study patients.

@ast

Resection and survival in glio ...... nalysis of ALA study patients.

@en

type

label

Resection and survival in glio ...... nalysis of ALA study patients.

@ast

Resection and survival in glio ...... nalysis of ALA study patients.

@en

prefLabel

Resection and survival in glio ...... nalysis of ALA study patients.

@ast

Resection and survival in glio ...... nalysis of ALA study patients.

@en

P1433

Q33356349-DDBB67BE-0A0B-4092-8E7E-66E022F87B8A

P1476

Q33356349-FB7B5E08-25AA-4259-910F-BADA52A3F9F5

P2093

Q33356349-1957F259-F473-42D4-8608-83D1D3554EF8

Q33356349-4A0DF582-8778-41B8-9248-CFB702F2AFED

Q33356349-5A0446F7-03ED-49BC-B432-B3541C192EC5

Q33356349-8F20C42B-0A0C-47F4-8945-3D9323BE1558

Q33356349-F8D3C8E1-BE09-4C3E-8939-AD68DE0449A2

P2860

Q33356349-043B741E-EA3C-400B-985E-00849BDC99FF

Q33356349-04AF6C65-A00B-4B7B-AA9E-C691811ADDCA

Q33356349-08DB94C7-F197-4BEB-9183-448EB31C5356

Q33356349-13DED21F-78E1-48C2-B49B-F9408AB5E6DC

Q33356349-3AE43D2B-75AE-4833-B515-B1D5D8197D54

Q33356349-3C050BFD-93F3-4E1A-B8C0-B5A8A32B7F11

Q33356349-4F121C32-D680-4DC6-A1B4-A3B90F05929E

Q33356349-57F11369-13F4-4D20-BD69-D981EDD66A00

Q33356349-6EAD7AE3-49F2-4078-AA8B-406E487DB2C1

Q33356349-70811D4B-4CB5-4717-8BA7-7083CC25AEB0

P304

Q33356349-9332FEE2-3972-47C4-89DC-BC701F42FA63

P31

Q33356349-55FCFEAD-A7E7-490B-816F-799693B11E12

P356

Q33356349-44453BD3-622A-4350-9F0E-39C43ACD4CDC

P433

Q33356349-8F6AD49A-5C9E-458F-B787-16438D628ECB

P478

Q33356349-1C87DAA7-A403-41A5-A94E-25C5CA0EE070

P577

Q33356349-8BC4409A-7085-408C-B470-28F47CC50132

P5875

Q33356349-45D8957D-A2CA-4448-8A69-DFDFCF0E2699

P698

Q33356349-EFDE0E9D-4D2C-40A7-AFD2-BE62A101AAB7

P932

Q33356349-1A75067D-AD65-4016-A06B-E94E4686A13A

P356

15228517-2008-052

P1433

P1476

Resection and survival in glio ...... nalysis of ALA study patients.

@en

P2093

ALA Glioma Study Group

http://www.w3.org/2001/XMLSchema#string

Andrea Bink

http://www.w3.org/2001/XMLSchema#string

Gabriele Schackert

http://www.w3.org/2001/XMLSchema#string

Uwe Pichlmeier

http://www.w3.org/2001/XMLSchema#string

Walter Stummer

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli

Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.

Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.

Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients

P304

1025-1034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1215/15228517-2008-052

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23138148

http://www.w3.org/2001/XMLSchema#string

P698

18667747

http://www.w3.org/2001/XMLSchema#string

P932

2719000

http://www.w3.org/2001/XMLSchema#string